AIDS Drug Assistance Program (ADAP) Emergency Relief Fund (ERF)

The summary for the AIDS Drug Assistance Program (ADAP) Emergency Relief Fund (ERF) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the Health Resources and Services Administration, which is the U.S. government agency offering this grant.

AIDS Drug Assistance Program (ADAP) Emergency Relief Fund (ERF): This notice announces the opportunity to apply for funding under the Ryan White HIV/AIDS Program (RWHAP) Part B AIDS Drug Assistance Program (ADAP) Emergency Relief Funds (ERF). The Health Resources and Services Administration (HRSA), HIV/AIDS Bureau (HAB), Division of State HIV/AIDS Programs (DSHAP) administers this program. ADAP ERF awards are intended for states/territories that demonstrate the need for additional resources to prevent, reduce, or eliminate ADAP waiting lists, including through cost-containment measures (for example, the provision of health insurance assistance). HRSA will base ADAP ERF awards upon applicants' ability to successfully demonstrate need for additional funding. An external objective review committee (ORC) will evaluate this need based on criteria published in this notice of funding opportunity (NOFO), with priority given to addressing existing waiting lists. HRSA first funded the ERF initiative in August 2010, when numerous states/territories were experiencing ADAP waiting lists. At the time of this NOFO publication, there are no ADAP waiting lists. States/territories that established a waiting list since the publication of this NOFO must report the waiting list to HRSA immediately and use funding awarded under this NOFO to remove clients from the waiting list. Previously, eligibility for this funding was limited to states/territories that had historically imposed waiting lists. This year, HRSA expects additional state/territory impact on ADAPs due to the economic downturn, resulting in more potential clients in need of ADAP services due to client loss of income and/or client loss of health care coverage. States/territories may use ERF funds to address current or projected increases in treatment needs aligned with ending the HIV epidemic or other unanticipated increases in the number of clients in the program. Applicants are encouraged to consider how their proposed activities with the ADAP ERF funding support HRSA's emphasis on innovation, collaboration, impact, and effectiveness.